Conclusion: The findings suggest that aspirin discontinuation could increase the risk of stroke during the first 4 weeks after treatment interruption.

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

International guidelines now recommend aspirin withdrawal in some patients with coronary disease, and such recommendations should be extended to other patient groups after scientific review of the ...

One of the most commonly used types of medication to prevent strokes is blood thinners. These medications reduce the risk of ...

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in ...

The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

Opens in a new tab or window Treating patients with aspirin after completion of standard ... clinically significant cardiovascular disease or stroke. "Thus, patients with coexisting colorectal ...